Minas P Economides Amishi Y Shah Camilo Jimenez Mouhammed A Habra Monica Desai Matthew T Campbell
10.3389/fendo.2020.594264
Front Endocrinol (Lausanne)
2020 Nov 27;11:594264.
cabozantinib immunotherapy nivolumab paraganglioma pheochromocytoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/33329398/
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Paraganglioma / drug therapy
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Paraganglioma / drug therapy Case Reports Adult Anilides / administration & dosage Humans Male Nivolumab / administration & dosage Paraganglioma / secondary Prognosis Pyridines / administration & dosage Anilides Pyridines cabozantinib Nivolumab
PMC7731902
33329398
A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature
2020